These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 23175556)
21. Efficacy of oral and intravenous artesunate in male Tanzanian adults with Plasmodium falciparum malaria and in vitro susceptibility to artemisinin, chloroquine, and mefloquine. Alin MH; Kihamia CM; Bjorkman A; Bwijo BA; Premji Z; Mtey GJ; Ashton M Am J Trop Med Hyg; 1995 Dec; 53(6):639-45. PubMed ID: 8561267 [TBL] [Abstract][Full Text] [Related]
22. Population pharmacokinetics of mefloquine given as a 3-day artesunate-mefloquine in patients with acute uncomplicated Plasmodium falciparum malaria in a multidrug-resistant area along the Thai-Myanmar border. Hoglund RM; Ruengweerayut R; Na-Bangchang K Malar J; 2018 Sep; 17(1):322. PubMed ID: 30176888 [TBL] [Abstract][Full Text] [Related]
23. Compliance with a three-day course of artesunate-mefloquine combination and baseline anti-malarial treatment in an area of Thailand with highly multidrug resistant falciparum malaria. Congpuong K; Bualombai P; Banmairuroi V; Na-Bangchang K Malar J; 2010 Feb; 9():43. PubMed ID: 20132537 [TBL] [Abstract][Full Text] [Related]
24. Plasmodium falciparum clearance is rapid and pitting independent in immune Malian children treated with artesunate for malaria. Ndour PA; Lopera-Mesa TM; Diakité SA; Chiang S; Mouri O; Roussel C; Jauréguiberry S; Biligui S; Kendjo E; Claessens A; Ciceron L; Mazier D; Thellier M; Diakité M; Fairhurst RM; Buffet PA J Infect Dis; 2015 Jan; 211(2):290-7. PubMed ID: 25183768 [TBL] [Abstract][Full Text] [Related]
25. Artesunate dose escalation for the treatment of uncomplicated malaria in a region of reported artemisinin resistance: a randomized clinical trial. Bethell D; Se Y; Lon C; Tyner S; Saunders D; Sriwichai S; Darapiseth S; Teja-Isavadharm P; Khemawoot P; Schaecher K; Ruttvisutinunt W; Lin J; Kuntawungin W; Gosi P; Timmermans A; Smith B; Socheat D; Fukuda MM PLoS One; 2011; 6(5):e19283. PubMed ID: 21603629 [TBL] [Abstract][Full Text] [Related]
26. Randomized trials of artemisinin-piperaquine, dihydroartemisinin-piperaquine phosphate and artemether-lumefantrine for the treatment of multi-drug resistant falciparum malaria in Cambodia-Thailand border area. Song J; Socheat D; Tan B; Seila S; Xu Y; Ou F; Sokunthea S; Sophorn L; Zhou C; Deng C; Wang Q; Li G Malar J; 2011 Aug; 10():231. PubMed ID: 21827706 [TBL] [Abstract][Full Text] [Related]
27. Optimal sampling designs for estimation of Plasmodium falciparum clearance rates in patients treated with artemisinin derivatives. Flegg JA; Guérin PJ; Nosten F; Ashley EA; Phyo AP; Dondorp AM; Fairhurst RM; Socheat D; Borrmann S; Björkman A; Mårtensson A; Mayxay M; Newton PN; Bethell D; Se Y; Noedl H; Diakite M; Djimde AA; Hien TT; White NJ; Stepniewska K Malar J; 2013 Nov; 12():411. PubMed ID: 24225303 [TBL] [Abstract][Full Text] [Related]
28. Efficacy and effectiveness of dihydroartemisinin-piperaquine versus artesunate-mefloquine in falciparum malaria: an open-label randomised comparison. Smithuis F; Kyaw MK; Phe O; Aye KZ; Htet L; Barends M; Lindegardh N; Singtoroj T; Ashley E; Lwin S; Stepniewska K; White NJ Lancet; 2006 Jun; 367(9528):2075-85. PubMed ID: 16798391 [TBL] [Abstract][Full Text] [Related]
29. Current status of artemisinin-resistant falciparum malaria in South Asia: a randomized controlled artesunate monotherapy trial in Bangladesh. Starzengruber P; Swoboda P; Fuehrer HP; Khan WA; Hofecker V; Siedl A; Fally M; Graf O; Teja-Isavadharm P; Haque R; Ringwald P; Noedl H PLoS One; 2012; 7(12):e52236. PubMed ID: 23272227 [TBL] [Abstract][Full Text] [Related]
30. A randomized trial of artemether-lumefantrine versus mefloquine-artesunate for the treatment of uncomplicated multi-drug resistant Plasmodium falciparum on the western border of Thailand. Hutagalung R; Paiphun L; Ashley EA; McGready R; Brockman A; Thwai KL; Singhasivanon P; Jelinek T; White NJ; Nosten FH Malar J; 2005 Sep; 4():46. PubMed ID: 16179089 [TBL] [Abstract][Full Text] [Related]
31. Life-saving rectal artesunate for complicated malaria in children. Pengsaa K; Sirivichayakul C; Na-Bangchang K; Thaiarporn I; Chaivisuth A; Wongsuwan A; Attanath P; Pojjaroen-Anant C; Wisetsing P; Chanthavanich P; Sabchareon A Southeast Asian J Trop Med Public Health; 2005 May; 36(3):597-601. PubMed ID: 16124423 [TBL] [Abstract][Full Text] [Related]
32. Efficacy and Safety of Pyronaridine-Artesunate for Treatment of Uncomplicated Plasmodium falciparum Malaria in Western Cambodia. Leang R; Canavati SE; Khim N; Vestergaard LS; Borghini Fuhrer I; Kim S; Denis MB; Heng P; Tol B; Huy R; Duparc S; Dondorp AM; Menard D; Ringwald P Antimicrob Agents Chemother; 2016 Jul; 60(7):3884-90. PubMed ID: 26926629 [TBL] [Abstract][Full Text] [Related]
33. Pyronaridine-artesunate versus mefloquine plus artesunate for malaria. Rueangweerayut R; Phyo AP; Uthaisin C; Poravuth Y; Binh TQ; Tinto H; Pénali LK; Valecha N; Tien NT; Abdulla S; Borghini-Fuhrer I; Duparc S; Shin CS; Fleckenstein L; N Engl J Med; 2012 Apr; 366(14):1298-309. PubMed ID: 22475593 [TBL] [Abstract][Full Text] [Related]
34. Monitoring for Plasmodium falciparum drug resistance to artemisinin and artesunate in Binh Phuoc Province, Vietnam: 1998-2009. Thanh NV; Toan TQ; Cowman AF; Casey GJ; Phuc BQ; Tien NT; Hung NM; Biggs BA Malar J; 2010 Jun; 9():181. PubMed ID: 20573274 [TBL] [Abstract][Full Text] [Related]
35. Therapeutic efficacy of artesunate in the treatment of uncomplicated Plasmodium falciparum malaria and anti-malarial, drug-resistance marker polymorphisms in populations near the China-Myanmar border. Huang F; Tang L; Yang H; Zhou S; Sun X; Liu H Malar J; 2012 Aug; 11():278. PubMed ID: 22898135 [TBL] [Abstract][Full Text] [Related]
36. Therapeutic efficacy of fixed dose artesunate-mefloquine for the treatment of acute, uncomplicated Plasmodium falciparum malaria in Kampong Speu, Cambodia. Leang R; Ros S; Duong S; Navaratnam V; Lim P; Ariey F; Kiechel JR; Ménard D; Taylor WR Malar J; 2013 Sep; 12():343. PubMed ID: 24060207 [TBL] [Abstract][Full Text] [Related]
37. Comparison of oral artesunate and quinine plus tetracycline in acute uncomplicated falciparum malaria. Karbwang J; Na-Bangchang K; Thanavibul A; Bunnag D; Chongsuphajaisiddhi T; Harinasuta T Bull World Health Organ; 1994; 72(2):233-8. PubMed ID: 8205643 [TBL] [Abstract][Full Text] [Related]
38. Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal study. Phyo AP; Nkhoma S; Stepniewska K; Ashley EA; Nair S; McGready R; ler Moo C; Al-Saai S; Dondorp AM; Lwin KM; Singhasivanon P; Day NP; White NJ; Anderson TJ; Nosten F Lancet; 2012 May; 379(9830):1960-6. PubMed ID: 22484134 [TBL] [Abstract][Full Text] [Related]
39. Population pharmacokinetic and pharmacodynamic properties of artesunate in patients with artemisinin sensitive and resistant infections in Southern Myanmar. Lohy Das JP; Kyaw MP; Nyunt MH; Chit K; Aye KH; Aye MM; Karlsson MO; Bergstrand M; Tarning J Malar J; 2018 Mar; 17(1):126. PubMed ID: 29566683 [TBL] [Abstract][Full Text] [Related]
40. Pfmdr1 copy number and arteminisin derivatives combination therapy failure in falciparum malaria in Cambodia. Lim P; Alker AP; Khim N; Shah NK; Incardona S; Doung S; Yi P; Bouth DM; Bouchier C; Puijalon OM; Meshnick SR; Wongsrichanalai C; Fandeur T; Le Bras J; Ringwald P; Ariey F Malar J; 2009 Jan; 8():11. PubMed ID: 19138391 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]